CAR T cells ignite antitumor immunity
Broadening immune responses through antigen spreading remains the ‘Holy Grail’ of cancer immunotherapy. A study by Ma and colleagues reveals that vaccine boosting of chimeric antigen receptor (CAR)-T cells in mice promotes endogenous immunity and elicits antigen spread to eliminate antigenically het...
Saved in:
Published in | Trends in immunology Vol. 44; no. 10; pp. 748 - 750 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
01.10.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Broadening immune responses through antigen spreading remains the ‘Holy Grail’ of cancer immunotherapy. A study by Ma and colleagues reveals that vaccine boosting of chimeric antigen receptor (CAR)-T cells in mice promotes endogenous immunity and elicits antigen spread to eliminate antigenically heterogenous solid tumors through a mechanism crucially dependent on interferon (IFN)γ.
Broadening immune responses through antigen spreading remains the ‘Holy Grail’ of cancer immunotherapy. A study by Ma and colleagues reveals that vaccine boosting of chimeric antigen receptor (CAR)-T cells in mice promotes endogenous immunity and elicits antigen spread to eliminate antigenically heterogenous solid tumors through a mechanism crucially dependent on interferon (IFN)γ. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1471-4906 1471-4981 |
DOI: | 10.1016/j.it.2023.08.002 |